APO RESEARCH · REPORT
Silymarin
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
Product & engineering
Understand the product.
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
Selected research
Industry Growth & Trends
Global Silymarin Industry Growth and Trends Forecast to 2032
Market perspective
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
The top players cover LIVERD PHARMA, TY Pharmaceutical, KEB Biotech, etc. The Top 3 players in Global Silymarin market revenue was 50.46% in 2019, while the share of top 5 players was 61.99%. TY Pharmaceutical is the leading supplier of Silymarin, the production of which reached 438 MT in 2019, accounting for about 18.81% of the Global market. Market concentration is high. Except policy affect, downstream demand is the key influence factor to the market.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Silymarin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Silymarin market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Silymarin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Silymarin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Silymarin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Silymarin Market by Company
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb
Silymarin Segment by Type
Silymarin Extracted by Acetone
Silymarin Extracted by Ethyl Acetate
Silymarin Extracted by Ethanol
Water Soluble Silymarin
Silymarin Segment by Application
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
Silymarin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Silymarin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Silymarin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Silymarin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Silymarin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Silymarin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Silymarin Extracted by Acetone
- Silymarin Extracted by Ethyl Acetate
- Silymarin Extracted by Ethanol
- Water Soluble Silymarin
Applications
- Pharma and Healthcare
- Food Additives
- Cosmetic and Skin Care
- Others
Companies covered
- LIVERD PHARMA
- Huacheng Pharmaceutical
- TY Pharmaceutical
- Teva API
- KEB Biotech
- Shengbo Silymarin
- Panjin Fengrui
- Jiaherb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Silymarin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Silymarin Sales Estimates and Forecasts (2021-2032)
- 1.3 Silymarin Market by Type
- 1.3.1 Silymarin Extracted by Acetone
- 1.3.2 Silymarin Extracted by Ethyl Acetate
- 1.3.3 Silymarin Extracted by Ethanol
- 1.3.4 Water Soluble Silymarin
- 1.4 Global Silymarin Market Size by Type
- 1.4.1 Global Silymarin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Silymarin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Silymarin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Silymarin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Silymarin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Silymarin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Silymarin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Silymarin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Silymarin Industry Trends
- 2.2 Silymarin Industry Drivers
- 2.3 Silymarin Industry Opportunities and Challenges
- 2.4 Silymarin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Silymarin Revenue (2021-2026)
- 3.2 Global Top Players by Silymarin Sales (2021-2026)
- 3.3 Global Top Players by Silymarin Price (2021-2026)
- 3.4 Global Silymarin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Silymarin Major Company Production Sites & Headquarters
- 3.6 Global Silymarin Company, Product Type & Application
- 3.7 Global Silymarin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Silymarin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Silymarin Players Market Share by Revenue in 2025
- 3.8.3 2025 Silymarin Tier 1, Tier 2, and Tier 3
4 Silymarin Regional Status and Outlook
- 4.1 Global Silymarin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Silymarin Historic Market Size by Region
- 4.2.1 Global Silymarin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Silymarin Sales in Value by Region (2021-2026)
- 4.2.3 Global Silymarin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Silymarin Forecasted Market Size by Region
- 4.3.1 Global Silymarin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Silymarin Sales in Value by Region (2027-2032)
- 4.3.3 Global Silymarin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Silymarin by Application
- 5.1 Silymarin Market by Application
- 5.1.1 Pharma and Healthcare
- 5.1.2 Food Additives
- 5.1.3 Cosmetic and Skin Care
- 5.1.4 Others
- 5.2 Global Silymarin Market Size by Application
- 5.2.1 Global Silymarin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Silymarin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Silymarin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Silymarin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Silymarin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Silymarin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Silymarin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Silymarin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 LIVERD PHARMA
- 6.1.1 LIVERD PHARMA Company Information
- 6.1.2 LIVERD PHARMA Business Overview
- 6.1.3 LIVERD PHARMA Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 LIVERD PHARMA Silymarin Product Portfolio
- 6.1.5 LIVERD PHARMA Recent Developments
- 6.2 Huacheng Pharmaceutical
- 6.2.1 Huacheng Pharmaceutical Company Information
- 6.2.2 Huacheng Pharmaceutical Business Overview
- 6.2.3 Huacheng Pharmaceutical Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Huacheng Pharmaceutical Silymarin Product Portfolio
- 6.2.5 Huacheng Pharmaceutical Recent Developments
- 6.3 TY Pharmaceutical
- 6.3.1 TY Pharmaceutical Company Information
- 6.3.2 TY Pharmaceutical Business Overview
- 6.3.3 TY Pharmaceutical Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 TY Pharmaceutical Silymarin Product Portfolio
- 6.3.5 TY Pharmaceutical Recent Developments
- 6.4 Teva API
- 6.4.1 Teva API Company Information
- 6.4.2 Teva API Business Overview
- 6.4.3 Teva API Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Teva API Silymarin Product Portfolio
- 6.4.5 Teva API Recent Developments
- 6.5 KEB Biotech
- 6.5.1 KEB Biotech Company Information
- 6.5.2 KEB Biotech Business Overview
- 6.5.3 KEB Biotech Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 KEB Biotech Silymarin Product Portfolio
- 6.5.5 KEB Biotech Recent Developments
- 6.6 Shengbo Silymarin
- 6.6.1 Shengbo Silymarin Company Information
- 6.6.2 Shengbo Silymarin Business Overview
- 6.6.3 Shengbo Silymarin Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shengbo Silymarin Silymarin Product Portfolio
- 6.6.5 Shengbo Silymarin Recent Developments
- 6.7 Panjin Fengrui
- 6.7.1 Panjin Fengrui Company Information
- 6.7.2 Panjin Fengrui Business Overview
- 6.7.3 Panjin Fengrui Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Panjin Fengrui Silymarin Product Portfolio
- 6.7.5 Panjin Fengrui Recent Developments
- 6.8 Jiaherb
- 6.8.1 Jiaherb Company Information
- 6.8.2 Jiaherb Business Overview
- 6.8.3 Jiaherb Silymarin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Jiaherb Silymarin Product Portfolio
- 6.8.5 Jiaherb Recent Developments
7 North America by Country
- 7.1 North America Silymarin Sales by Country
- 7.1.1 North America Silymarin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Silymarin Sales by Country (2021-2026)
- 7.1.3 North America Silymarin Sales Forecast by Country (2027-2032)
- 7.2 North America Silymarin Market Size by Country
- 7.2.1 North America Silymarin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Silymarin Market Size by Country (2021-2026)
- 7.2.3 North America Silymarin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Silymarin Sales by Country
- 8.1.1 Europe Silymarin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Silymarin Sales by Country (2021-2026)
- 8.1.3 Europe Silymarin Sales Forecast by Country (2027-2032)
- 8.2 Europe Silymarin Market Size by Country
- 8.2.1 Europe Silymarin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Silymarin Market Size by Country (2021-2026)
- 8.2.3 Europe Silymarin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Silymarin Sales by Country
- 9.1.1 Asia-Pacific Silymarin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Silymarin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Silymarin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Silymarin Market Size by Country
- 9.2.1 Asia-Pacific Silymarin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Silymarin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Silymarin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Silymarin Sales by Country
- 10.1.1 South America Silymarin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Silymarin Sales by Country (2021-2026)
- 10.1.3 South America Silymarin Sales Forecast by Country (2027-2032)
- 10.2 South America Silymarin Market Size by Country
- 10.2.1 South America Silymarin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Silymarin Market Size by Country (2021-2026)
- 10.2.3 South America Silymarin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Silymarin Sales by Country
- 11.1.1 Middle East and Africa Silymarin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Silymarin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Silymarin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Silymarin Market Size by Country
- 11.2.1 Middle East and Africa Silymarin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Silymarin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Silymarin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Silymarin Value Chain Analysis
- 12.1.1 Silymarin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Silymarin Production Mode & Process
- 12.2 Silymarin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Silymarin Distributors
- 12.2.3 Silymarin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst